Quinten Health innovates at DIA Basel 2023 with Real-World Digital Twins for Clinical Trial Optimization

– 1 min read

We are thrilled to announce that March 23rd, Quinten Health will animate a ๐—Ÿ๐—ถ๐˜ƒ๐—ฒ ๐—ฆ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป at ๐——๐—œ๐—” ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฏ.
Billy Amzal, CEO of Quinten Health andย Alexandre Templier, President of Quinten Health, will invite industry and regulatory leaders to discuss why and how to extend current clinical evidence with the projection of long-term real-world medical and economic value from R&D stages.

โ€œOur disease and care simulators leverage the best existing data networks/platforms and combine state-of-the-art AI/ML, predictive modeling, and pharmaco-epidemiology. We are building reference โ€˜virtual twinsโ€™ generators in diseases with high unmet needs to accelerate drug development and patient access to the right drugsโ€ comments Drย Billy Amzal, CEO of Quinten Health and a pioneer expert in disease modeling since 1999.

โ€œOur disease-centric models will ultimately transform the way drugs are developed and evaluated, and enable precision careโ€ complements Drย Alexandre Templier, President of Quinten Health.

See the full press release in the link below.